Back

Lipoprotein(a), smoking, and diabetes are additive, but not interactive risk factors for major adverse cardiovascular events after acute coronary syndrome: An analysis of the ODYSSEY OUTCOMES trial

31 August 2026 (12:00 - 12:12)
Organised by: Logo
Congress Presentation Part of: Lipids and myocardial infarction Lipids ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Gregory Schwartz

University of Colorado School of Medicine, Aurora (United States of America)

4 More presentations in this session

Presentation thumbnail
Sex differences in lipid management among high-risk patients without prior myocardial infarction or stroke: results from the VESALIUS-REAL global study
Associate Professor E. Hagstrom (Uppsala, SE)
Abstract Slides
Presentation thumbnail
Efficacy and safety of SYH2053 in patients with primary hypercholesterolemia or mixed dyslipidemia: a phase II, multicenter, randomized, double-blind, placebo- and active-controlled trial
Doctor F. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Extreme HDL-C associated increased mortality is explained by confounding due to progressively increasing alcohol-induced multisystem morbidity
Doctor B. Ference (Cambridge, GB)
Abstract Slides
Presentation thumbnail
FH genotype stratifies LDL-C–lowering response and improves diagnostic discrimination in severe hypercholesterolemia
Doctor J. Bernhard (Vienna, AT)
Abstract Slides

Access the full session

Session thumbnail
Lipids and myocardial infarction
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of lipoprotein(a) as a residual risk on long-term cardiovascular outcomes in patients with acute coronary syndrome treated with statin
27 August 2021
thumbnail
Congress Presentation
Pharmacodynamic effects of vorapaxar as an add-on antiplatelet therapy in patients with and without diabetes mellitus: the optimizing anti-platelet therapy in diabetes mellitus (OPTIMUS)-5 study
1 September 2019
thumbnail
Congress Presentation
The presence of adverse atherosclerotic coronary plaque features is associated with diabetes
9 May 2021
thumbnail
Congress Presentation
Cardiovascular risk factors in patients with and without a history of atherosclerotic cardiovascular disease in the SANTORINI study and estimation of risk
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources